Aortic root ectasia in patients with acromegaly: Experience at a single center

Clinical Endocrinology

Volumn 75, Issue 4, 2011, Pages 495-500

  Casini, Alessandra Ferri ^a   Neto, Leonardo Vieira ^a,b   Fontes, Rosita ^c   França, Rodrigo Fraguas ^d   Xavier, Sérgio Salles ^a   Gadelha, Mônica Roberto ^a,e  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b HOSPITAL DA LAGOA   (Brazil)

^c Medicina Diagnostica ^*  (Brazil)

^d Cardio Diagnostico   (Brazil)

^e Instituto Estadual de Diabetes e Endocrinologia Luiz Capriglione   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ACROMEGALY; ADULT; AORTA DISEASE; AORTA ROOT; AORTA ROOT ECTASIA; ARTERY DIAMETER; ARTICLE; CARDIAC PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE DURATION; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; SEX DIFFERENCE;

ACROMEGALY; ADULT; AORTIC VALVE; DILATATION, PATHOLOGIC; ECHOCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 80052527443     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2011.04067.x     Document Type: Article

References (29)

1. Ayuk, J., Clayton, R.N., Holder, G., et al. (2004) Growth hormone and pituitary radiotherapy, but not serum insulin-like growth factor-I concentrations, predict excess mortality in patients with acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 1613-1617. (Pubitemid 38507910)
2. Bates, A.S., Van't Hoff, W., Jones, J.M., et al. (1993) An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine, 86, 293-299. (Pubitemid 23160830)
3. Dekkers, O.M., Biermasz, N.R., Pereira, A.M., et al. (2008) Mortality in acromegaly: a metaanalysis. Journal of Clinical Endocrinology and Metabolism, 93, 61-67.
4. Holdaway, I.M., Bolland, M.J., &, Gamble, G.D., (2008) A meta-analysis of the effect of lowering serum levels of GH and IGF-I on mortality in acromegaly. European Journal of Endocrinology, 159, 89-95.
5. Orme, S.M., McNally, R.J., Cartwright, R.A., et al. (1998) Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. Journal of Clinical Endocrinology and Metabolism, 83, 2730-2734. (Pubitemid 28493768)
6. Rajasoorya, C., Holdaway, I.M., Wrightson, P., et al. (1994) Determinants of clinical outcome and survival in acromegaly. Clin Endocrinol (Oxf), 41, 95-102. (Pubitemid 24232533)
7. Swearingen, B., Barker, F.G. 2nd, Katznelson, L., et al. (1998) Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. Journal of Clinical Endocrinology and Metabolism, 83, 3419-3426. (Pubitemid 28500866)
8. Wu, T.E., Lin, H.D., Lu, R.A., et al. (2010) The role of insulin-like growth factor-1 and growth hormone in the mortality of patients with acromegaly after trans-sphenoidal surgery. Growth Hormone and IGF Research, 20, 411-415.
9. Colao, A., Ferone, D., Marzullo, P., et al. (2004) Systemic complications of acromegaly: epidemiology, pathogenesis, and management. Endocrine Reviews, 25, 102-152. (Pubitemid 38269977)
10. Sacca, L., Cittadini, A., &, Fazio, S., (1994) Growth hormone and the heart. Endocrine Reviews, 15, 555-573. (Pubitemid 24328207)
11. Bondanelli, M., Ambrosio, M.R., &, degli Uberti, E.C., (2001) Pathogenesis and prevalence of hypertension in acromegaly. Pituitary, 4, 239-249.
12. Casini, A.F., Araujo, P.B., Fontes, R., et al. (2006) Cardiac morphology and performance alterations and analysis of determinant factors of left ventricular hypertrophy in 40 patients with acromegaly. Arq Bras Endocrinology Metabolism, 50, 82-90. (Pubitemid 43748325)
13. Delafontaine, P., (1995) Insulin-like growth factor I and its binding proteins in the cardiovascular system. Cardiovasc Research, 30, 825-834.
14. Colao, A., Marzullo, P., Di Somma, C., et al. (2001) Growth hormone and the heart. Clinical Endocrinology (Oxf), 54, 137-154. (Pubitemid 32194446)
15. Frustaci, A., Chimenti, C., Setoguchi, M., et al. (1999) Cell death in acromegalic cardiomyopathy. Circulation, 99, 1426-1434. (Pubitemid 29140907)
16. Lie, J.T., (1980) Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. American Heart Journal, 100, 41-52. (Pubitemid 10083045)
17. Pereira, A.M., van Thiel, S.W., Lindner, J.R., et al. (2004) Increased prevalence of regurgitant valvular heart disease in acromegaly. Journal of Clinical Endocrinology and Metabolism, 89, 71-75. (Pubitemid 38183861)
18. Colao, A., Spinelli, L., Marzullo, P., et al. (2003) High prevalence of cardiac valve disease in acromegaly: an observational, analytical, case-control study. Journal of Clinical Endocrinology and Metabolism, 88, 3196-3201. (Pubitemid 36877494)
19. van Karnebeek, C.D., Naeff, M.S., Mulder, B.J., et al. (2001) Natural history of cardiovascular manifestations in Marfan syndrome. Archives of Disease in Childhood, 84, 129-137. (Pubitemid 32150328)
20. van der Klaauw, A.A., Bax, J.J., Smit, J.W., et al. (2008) Increased aortic root diameters in patients with acromegaly. European Journal of Endocrinology, 159, 97-103.
21. Hiratzka, L.F., Bakris, G.L., Beckman, J.A., et al. (2010) 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM Guidelines for the diagnosis and management of patients with thoracic aortic disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology,American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons,and Society for Vascular Medicine. Journal of the Americal College of Cardiology, 55, e27-e129.
22. Albuquerque, L.C., Braile, D.M., Palma, J.H., et al. (2009) Guidelines for surgery of aortic diseases from the Brazilian Society of Cardiovascular Surgery: updated in 2009. Revista Brasileira de Cirurgia Cardiovascular, 24, 7s-33s.
23. Thompson, B.J., Shang, C.A., &, Waters, M.J., (2000) Identification of genes induced by growth hormone in rat liver using cDNA arrays. Endocrinology, 141, 4321-4324.
24. Savage, D.D., Henry, W.L., Eastman, R.C., et al. (1979) Echocardiographic assessment of cardiac anatomy and function in acromegalic patients. American Journal of Medicine, 67, 823-829.
25. Esteves, J.P., Santos, R.A.S., &, Gordan, P., (2007) V Brazilian guideline in arterial hypertension. Arquivos Brasileiros de Cardiologia, 89, 24-79.
26. Sahn, D.J., DeMaria, A., Kisslo, J., et al. (1978) Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements. Circulation, 58, 1072-1083. (Pubitemid 9091990)
27. Devereux, R.B., (1987) Detection of left ventricular hypertrophy by M-mode echocardiography. Anatomic validation, standardization, and comparison to other methods. Hypertension, 9, II19-II26.
28. Zoghbi, W.A., Enriquez-Sarano, M., Foster, E., et al. (2003) Recommendations for evaluation of the severity of native valvular regurgitation with two-dimensional and Doppler echocardiography. Journal of the American Society of Echocardiography, 16, 777-802. (Pubitemid 37391035)
29. Vasan, R.S., Larson, M.G., &, Levy, D., (1995) Determinants of echocardiographic aortic root size. The Framingham Heart Study. Circulation, 91, 734-740.